Category: In the News

Dr. Angie Beltsos Named Top Doctor in Chicago

We are excited to announce Dr. Angie Beltsos has been recognized in Chicago Magazine as one of the Top Doctors in the Chicago area.

Dr. Beltsos is the CEO and Chief Medical Officer of Vios Fertility Institute. She is double board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI).

To learn more about Dr. Beltsos, click here or schedule an appointment with her now.

Dr. Beltsos was chosen by Castle Connolly Medical Ltd., a leading research and information resource for patients looking to find the best medical care. Doctors do not pay to appear on Castle Connolly lists. Castle Connolly selects the list of Top Doctors based on peer nomination, research, review, and screening.

Congratulations Dr. Beltsos on your selection!

Dr. Ellen Hayes Named Top Doctor in Milwaukee

We are excited to announce Dr. Ellen Hayes has been recognized in Milwaukee Lifestyle Magazine as one of the Top Doctors in the Milwaukee area.

Dr. Hayes received her medical degree from Loyola University Chicago Stritch School of Medicine and completed her residency in Obstetrics and Gynecology at Medical College of Wisconsin. She completed her fellowship in Reproductive Endocrinology and Infertility at Emory University Medical Center.

To learn more about Dr. Hayes, click here or schedule an appointment with her now.

Dr. Hayes was chosen by Castle Connolly Medical Ltd., a leading research and information resource for patients looking to find the best medical care. Doctors do not pay to appear on Castle Connolly lists. Castle Connolly selects the list of Top Doctors based on peer nomination, research, review, and screening.

Congratulations Dr. Hayes on your selection!

Kindbody and Vios Fertility Institute Create Largest Women-led Fertility Care Company Serving Employers and Consumers

Kindbody Expands National Footprint with $1.15 Billion Valuation

NEW YORK, February 1, 2022 — Kindbody, a leading fertility and family-building care company, today announced that it has signed a merger agreement to acquire Vios Fertility Institute, a high-growth, innovative network of fertility clinics, to increase access to patient-centric, technology-driven care across the country. The transaction doubles Kindbody’s national footprint to 26 clinics with plans to expand to 40 retail locations by year’s end. Together, the companies performed nearly 10,000 fertility treatments in 2021 and served thousands of patients via their virtual and in-person services and is projected to double that in 2022.

Kindbody and Vios are both women-led companies driven by a mission and vision to revolutionize fertility care. Kindbody has transformed the fertility landscape through its design-forward clinics, state-of-the-art technology, and comprehensive virtual, at-home, and in-person care. Under the leadership of global fertility leader, Dr. Angeline Beltsos, Vios has developed deep experience and proven success in clinical operations, innovation, and scale. Vios clinics, located in Illinois, Michigan, Missouri, Oregon, Washington, and Wisconsin, will rebrand to Kindbody and integrate Kindbody’s proprietary patient portal, EMR (electronic medical record), and telehealth platform into the expanded operations to ensure a seamless continuum of care. 

As part of the transaction, Dr. Beltsos will become Chief Executive Officer, Clinical, designing and leading Kindbody’s medical team. Annbeth Eschbach has been promoted from President to Chief Executive Officer, Corporate, and will ensure operational excellence and consistent growth across the country; and, Vios President Gregory Poulos will assume the role of President of the combined company. Gina Bartasi, Kindbody’s Founder and CEO, will oversee a newly formed holding company leading expansion and vision for the combined entity.

“We founded Vios with a mission of an unparalleled patient experience and a vision of building families dreamed of by our patients,” said Dr. Angeline Beltsos, Founder and CEO of Vios. “Now, more people will have access to the personalized, high-touch experience they have come to expect from both Kindbody and Vios. Together, we have the opportunity to revolutionize fertility and family-building care and make it more accessible for all. I’m excited for what the future holds.“ 

Incoming Chief Executive Officer, Corporate, Annbeth Eschbach said, “We welcome Dr. Beltsos and the entire innovative Vios team to Kindbody. This union brings together two organizations with shared values and alignment around unwavering empathy for patient experience and outcomes. Together, we double our size, reach, and strengths in fertility care to serve our large enterprise clients and more patients everywhere.”

In addition to its proprietary technology, Kindbody has 78 employer clients serving more than 350,000 covered lives. “Large employers have been asking for more Kindbody locations to serve their employees and now, together with Vios, we’re better able to meet this demand. Angie is one of a kind and we couldn’t be more aligned philosophically around patient-centered care. After more than a decade of friendship and respect for her work, I’m thrilled to bring together our combined strengths to further accelerate our mission to make fertility care more affordable and accessible for all,” added Gina Bartasi.

Last year was a record year for consolidation in the digital healthcare sector with M&A activity up 44% from 2020, according to CB Insights State of Digital Health 2021 report. Investments in the US digital health market also skyrocketed in 2021 reaching a record $37.9B. The number of global digital health “unicorns,” or startups that reach a valuation of $1B, reached a record of 85, up 49% over the previous year, according to the report. Kindbody is uniquely positioned for success in the digital healthcare sector because it provides both care navigation and care delivery with more than 64 providers across the country. The announcement follows Kindbody’s expansion into at-home testing earlier this month, beginning with fertility hormone test kits for women and men. 

Kindbody was founded in 2018 and is led by a best in class leadership team including Founder and Chair, Gina Bartasi; CEO, Corporate, Annbeth Eschbach; CEO, Clinical, Dr. Angeline Beltsos; President, Gregory Poulos; Chief Medical Officer, Dr. Lynn Westphal; Chief Innovation Officer, Dr. Fahimeh Sasan, Chief Business and Legal Officer, Shilpa Patel; Chief Scientific Officer, Dr. Dean Morbeck; Chief Revenue Officer, Taryn Branca; Chief Marketing Officer, Anna Levikova; Chief Technology Officer, Richard Forsythe; Chief Accounting Officer, Brian Goldfarb; Chief Strategy Officer, Hannah Johnson; Chief Genomics Officer, Dr. Amber Cooper; Chief Clinical Research Officer, Dr. Roohi Jeelani; and Chief Financial Officer, Meredith Whitney. Kindbody’s Advisory Board includes Dr. Jacques Cohen, Larry Leisure, Cindy Gentry, Kerry Van Voris, Kimber Lockhart and Andy Grover. 

About Vios Fertility Institute

Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the U.S. with 13 locations in the Chicago, Detroit, Milwaukee, Portland, and St. Louis regions. Woman owned, the Vios mission is to help patients find their way to fertility health with the highest chances of success. Vios offers innovative, scientific, and cutting-edge treatment options along with an unparalleled patient experience. Visit www.ViosFertility.com to learn more.

About Kindbody

Kindbody is a leading fertility and family-building care company offering state-of-the-art technology, comprehensive virtual and in-person care, and an employer benefits solution. Kindbody’s clinically managed program includes fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption, as well as physical, mental, and emotional support from preconception through postpartum. Kindbody is the trusted fertility benefits solution for more than 78 employers, covering more than 350,000 lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at signature clinics, mobile clinics, and partner clinics. As the fertility benefits solution, the technology platform, and direct provider of high-quality care, Kindbody delivers a seamless, integrated experience with superior health outcomes at lower cost, making fertility care more affordable and accessible for all. Kindbody has raised $122 million in funding from leading investors including Perceptive Advisors, GV (formerly Google Ventures), RRE Capital, Claritas Health Ventures, Rock Springs Capital, NFP Ventures, and TQ Ventures. Visit www.kindbody.com and follow us on Instagram, Twitter, and Facebook.

Contact: Margaret Ryan, Head of Communications, Kindbody, [email protected]

Vios Fertility- St. Louis Welcomes CryoRobot

Vios Fertility Institute is proud to partner with TMRW to bring their CryoRobot to our St. Louis IVF lab, continuing to provide the best care for patients.

TMRW’s technology provides the world’s first fully automated specimen management platform (CryoRobot) that identifies, tracks, and manages frozen eggs and embryos – central to almost every IVF journey.  Our Chicago lab was the first in the world to adopt this revolutionary technology in early 2021.

“At Vios, we are committed to being an innovative fertility clinic and ensuring patients benefit from the technologies that protect the embryos and eggs they worked so hard to preserve to build their families,” explains Dr. Amber Cooper, Medical and IVF Practice Director of Vios Fertility Institute –St. Louis.  “Our company was the first in the world to embrace this technology because we know how important peace of mind and this protection is for patients.  While human error with manual tanks is rare, even one instance can be catastrophic which is why this new technology-driven platform that delivers digital tracking and thousands of daily safety checks is game-changing for our field.”

Read our full press release here.

Vios Fertility Institute Detroit Opens With Dr. Sasha Hakman

Known as one of the “fastest growing” clinics in the U.S,” Vios Fertility Institute expands it services to Detroit, Michigan with a new location scheduled to open in November.

Vios Fertility Institute Detroit, Dr. Sasha Hakman

“This marks our fourteenth clinic as Vios expands to provide innovative and patient-centric fertility care options Detroit and the surrounding areas,” explains Dr. Angie Beltsos, CEO and Chief Medical Officer.  “We are thrilled to return home to Michigan.”

A “Michigander,” Dr. Beltsos grew up in Ypsilanti/Ann Arbor and graduated from Michigan State University. Additionally, Vios physicians Dr. Roohi Jeelani and Dr. Erica Louden are both graduates of the esteemed Wayne State University School of Medicine in Detroit.  “We all have meaningful ties to Michigan and are excited to welcome Dr. Sasha Hakman who attended Michigan State University to our Detroit team!”

Dr. Hakman completed her Reproductive Endocrinology and Infertility fellowship at the Medical College of Georgia in Augusta and her OBGYN residency at Michigan State University.  She earned her medical degree from Saba University School of Medicine and her undergraduate degree from University of Toronto.  Highly skilled in all areas of reproductive health, Dr. Hakman has a particular expertise and interest in fertility preservation, PCOS, access to care, and the impacts of lifestyle on fertility. 

“I’m excited to join the Vios team to help bring our unique approach to fertility care services to the Detroit region,” explains Dr. Hakman.  “I have the best of both worlds -to be in a community I love while also being able to bring new innovations and cutting-edge technology to offer a greater chance of success for my patients.”

Vios Fertility Institute provides patients with innovative, cutting-edge fertility treatment options to meet the diverse needs of patient’s family planning goals.  As a team, they strive to be open-minded and forward thinking when evaluating new data, research and technologies that have the potential to improve the care and results they provide to patients. Above all, Vios is built on a foundation of excellent medical care and patient experience.

Vios Fertility Institute Detroit is located at 26400 W 12 Mile Rd Unit 140 Southfield, MI 48034 and accepts a wide range of insurance options. For more information or to make an appointment, please call 866.258.8467 or visit www.ViosFertility.com

Dr. Angie Beltsos honored in the Most Inspiring Business Leaders Making a Difference 2021 list

We are honored to have our very own Dr. Angie Beltsos featured in CIO Views 10 Most Inspiring Business Leaders Making a Difference 2021. Dr. Angie Beltsos leads Vios as Chief Medical Officer/CEO who is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991.

Dr. Beltsos believe in patient-focused care with success not only being measured by the amount of pregnancies but patient satisfaction and teamwork amongst Vios.

Read all about Dr. Angie Beltsos and her approach to fertility here.

Welcome Dr. Jared Robins and Dr. Kari von Goeben to Chicago Physician Team

Known as one of the “fastest growing & innovative fertility clinics in the U.S.,” Vios Fertility Institute announces the addition of two doctors to their team.  Dr. Kari von Goeben, of Florida Institute for Reproductive Medicine (FIRM) in Jacksonville and Dr. Jared Robins, of Northwestern Memorial HealthCare in Chicago, will join the dedicated group of Reproductive Endocrinology and Infertility specialists, nurse practitioners and lab directors servicing patients throughout Chicagoland with offices in West Loop, Wicker Park, Hoffman Estates, Glenview, Aurora, Crest Hill and Geneva.

Dr. von Goeben was recently recognized as one of Jacksonville’s “Top Doctors” while at FIRM.   Her areas of clinical interest include PCOS, fertility preservation, and the impacts of lifestyle factors as they are related to fertility. Dr. von Goeben completed her fellowship at UCLA/Cedars-Sinai, residency at UCLA, and medical school at Temple University. She is a current member of American Society of Reproductive Medicine, Society for Reproductive Endocrinology and Infertility and American College of Obstetricians and Gynecologists.

Dr. Robins served as Division Chief of Northwestern’s Reproductive Endocrinology and Infertility Division among other roles.  He has been awarded multiple grants for clinical trials and research in the field of reproductive medicine and is a well-known speaker and author.  Dr. Robins completed his fellowship at the University of Cincinnati, residency at Albert Einstein College of Medicine, and medical school at the State University of New York at Stony Brook (SUNY). He also holds an MBA from the Kellogg School of Management at Northwestern University. Dr. Robins is a current member of American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Society for Reproductive Investigation (elected member) and Society for Reproductive Endocrinology and Infertility.

Vios Fertility Institute is co-founded and led by CEO and Chief Medical Officer Dr. Angeline Beltsos, who is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991.  Dr. Beltsos, along with Vios physicians Dr. Roohi Jeelani, Dr. Erica Louden, and Dr. Scott Springer, will join Dr. von Goeben and Dr. Robins in seeing patients throughout the Chicagoland locations.

“We are absolutely thrilled to welcome these two seasoned fertility experts to Vios,” explains Dr. Beltsos.  “Dr. von Goeben and Dr. Robins are highly regarded for their experience and dedication to reproductive medicine.  Both our Chicagoland team and patients will benefit greatly from their progressive and patient-centric care which aligns with the Vios mission.”

Vios Fertility Institute provides patients with innovative, cutting-edge fertility treatment options to meet the diverse needs of patient’s family planning goals.  As a team, they strive to be open-minded and forward thinking when evaluating new data, research and technologies that have the potential to improve the care and results they provide to patients. Above all, Vios is built on a foundation of excellent medical care and patient experience.

Vios Fertility Institute accepts a wide range of insurance options. For more information or to make an appointment, please call 866.258.8467 or visit www.ViosFertility.com

About Vios Fertility:

Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the U.S. with 13 locations in the Chicago, Milwaukee, St. Louis, and Portland regions of the United States. Woman owned, the Vios mission is to help patients find their way to fertility health with the highest chances of success. Vios offers innovative, scientific, and cutting-edge treatment options along with an unparalleled patient experience. 

Announcing our newest location in the Pacific Northwest

We are thrilled to officially announce our newest clinic location near Portland, Oregon in the Pacific Northwest!

Dr. Shannel Adams and Dr. Angeline Beltsos

Vios is led by Chief Medical Officer/CEO Dr. Angie Beltsos, who is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. The new location will feature Shannel R. Adams, MD, FACOG, at the helm – a Portland native and double board-certified OB/GYN and reproductive endocrinologist.

“We are thrilled to have Dr. Adams leading our Pacific Northwest office,” explains Dr. Beltsos. “Her extensive knowledge and dedication to helping people build families is completely aligned with our Vios core values of vision, innovation, teamwork, and passion. Together, we look forward to leading the way toward expanded innovative and patient-centric fertility care options in the Pacific Northwest.”

Highly skilled in all areas of reproductive health, Dr. Adams has a particular expertise and interest in, fertility preservation, male fertility, third party reproduction, and holistic care of both mind and body. She received her undergraduate degree focusing on ethics from Duke University and went on to medical school at Oregon Health and Science University where she graduated in June 2010. Dr. Adams has been recognized with many awards for her contributions to the fields of medicine, reproductive endocrinology, and family planning and has presented numerous times on the topics of Oncofertility, fertility preservation, chromosome screening technologies, and infertility.  She credits her close-knit family and strong female role models with inspiring her to choose medicine as a profession and reproductive endocrinology as her specialty. Taking care of women and playing a trusted role in their healthcare is her passion. She considers it an honor to have an intimate role in the lives of her patients as they build their family or empower themselves with preservation options.

“I’m excited to join the Vios team to help expand our unique approach to fertility care services to the Pacific Northwest,” explains Dr. Adams. “I have the best of both worlds -to be in a community I love while also being able to bring new innovations and cutting-edge technology to offer a greater chance of success for my patients.”

Vios provides patients with innovative, cutting-edge fertility treatment options to meet the diverse needs of their family planning goals. As a team, they strive to be open-minded and forward thinking when evaluating new data, research and technologies that have the potential to improve the care and results they provide to patients.

Vios Fertility Institute – Pacific Northwest is located at 2501 NE 134th Street, Suite 100, Vancouver, Washington 98686.  For more information or to make an appointment, please call 866.955.0766 or complete our online form here.

Read the full press release.

Study finds COVID-19 does not cause female sterility

Protecting your health, and the health of your future family is important. Choices like vitamins and body weight can impact your goal to have a family. A new choice for women is whether they should receive the COVID-19 vaccine but a recent study has found the vaccine does not cause female sterility.

The study, published in ASRM’s Fertility & Sterility F&S Reports, showed no effect on a woman’s implantation rates or sustained implantation rates. This study which used frozen embryos of women who had the virus, vaccine, and neither showed no difference in rates from the three groups.

If you decide to move forward with getting vaccinated which vaccine should you get? According to American College of Obstetricians and Gynecologists (ACOG), all three vaccines are reasonable choices for patients undergoing a fertility journey or are pregnant. ACOG recommends the vaccine for women who are trying to get pregnant as well as already pregnant.

Getting the vaccine is your choice. Some information to remember is unvaccinated pregnant women have an increased risk of severe symptoms from COVID-19. If you get the virus while pregnant, your chances of needing intensive care and a ventilator are increased putting your unborn child at higher risk of preterm birth.

Vios is proud to support University of California – San Francisco’s ASPIRE study that seeks to assess the safety of pregnancy during the COVID-19 pandemic. We encourage our pregnant patients to enroll and contribute to this important research.

If you have questions about the COVID-19 vaccine contact a provider or learn more here.

Family Building for LGBTQIA+

June marks the beginning of Pride Month, commemorating the Stonewall Riots and celebrating the LGBTQIA+ community. June 1 also is #LGBTQFamiliesDay, created for individuals, families, and allies to celebrate and support LGBTQIA+ families. Family comes in many forms and everyone’s path to their family is unique to their journey. No matter what your journey is, anyone who struggles to build a family should have the opportunity including the LGTBQIA+ community. According to Resolve, between 2 million and 3.7 million children under the age of 18 have a LGTBQIA+ parent.

For most LGTBQIA+ single people and couples, the journey to building your dream family can have a different path than what may be considered “traditional”. At Vios, we are far from “traditional” ourselves and are an ally for the LGTBQIA+ community, here to help those wishing to become parents.

Recently, in the state of Illinois a bill was passed changing the definition of infertility providing insurance coverage to the LGBTQIA+ community. HB3709 amends the IL Insurance Code to provide coverage for the diagnosis and treatment of infertility shall be provided without discrimination on the basis of age, ancestry, color, disability, domestic partner status, gender, gender expression, gender identity, genetic information, marital status, national origin, race, religion, Sex, or sexual orientation. It removes provisions stating that “infertility” means the inability to conceive after one year of unprotected sexual intercourse or the inability to sustain a successful pregnancy. You can read more about this bill here.

There are three necessary components to make a baby: eggs, sperm, and a uterus. Thanks to improved medicine and technology, as well as generosity from third-party donors, same sex couples and single individuals have more options than ever to build the family of their dreams. From sperm donation and IUI, InVoCell for reciprocal IVF, egg donation, and gestational carrier Vios Fertility Institute can help bring the pieces together for all our patients. LGBTQ+ individuals and couples do not necessarily have a diagnosis of infertility so pregnancy rates per cycle are generally high in these cases.

If you need help financing your treatments learn more about our financing partners here!